Analysts Set Mettler-Toledo International, Inc. (NYSE:MTD) Target Price at $1,408.55

Posted by Francis Steltz on Jun 4th, 2026

Shares of Mettler-Toledo International, Inc. (NYSE:MTD – Get Free Report) have been given an average rating of “Hold” by the thirteen ratings firms that are covering the company, Marketbeat reports. Seven investment analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $1,408.5455.

A number of brokerages have weighed in on MTD. Wall Street Zen cut shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Stifel Nicolaus reduced their price target on shares of Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating on the stock in a research report on Monday, May 18th. JPMorgan Chase & Co. reduced their price target on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a research report on Monday, May 11th. Jefferies Financial Group raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and lifted their price target for the company from $1,400.00 to $1,450.00 in a research report on Friday, March 20th. Finally, Barclays reduced their price target on shares of Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th.

Get Our Latest Research Report on Mettler-Toledo International

Mettler-Toledo International Trading Down 0.0%

NYSE:MTD opened at $1,169.52 on Friday. The firm has a 50-day moving average price of $1,219.42 and a two-hundred day moving average price of $1,325.84. Mettler-Toledo International has a twelve month low of $1,023.05 and a twelve month high of $1,525.17. The company has a market capitalization of $23.64 billion, a P/E ratio of 27.43, a price-to-earnings-growth ratio of 2.44 and a beta of 1.27.

Mettler-Toledo International (NYSE:MTD – Get Free Report) last posted its earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share for the quarter, beating the consensus estimate of $8.70 by $0.21. The firm had revenue of $947.13 million during the quarter, compared to the consensus estimate of $943.14 million. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same period last year, the firm posted $8.19 EPS. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, equities research analysts predict that Mettler-Toledo International will post 46.6 earnings per share for the current year.

Institutional Trading of Mettler-Toledo International

A number of hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. raised its stake in shares of Mettler-Toledo International by 1.3% during the third quarter. Vanguard Group Inc. now owns 2,591,173 shares of the medical instruments supplier’s stock valued at $3,180,950,000 after purchasing an additional 34,466 shares during the period. Capital International Investors raised its stake in shares of Mettler-Toledo International by 12.7% during the fourth quarter. Capital International Investors now owns 969,067 shares of the medical instruments supplier’s stock valued at $1,351,064,000 after purchasing an additional 109,508 shares during the period. Alliancebernstein L.P. raised its stake in shares of Mettler-Toledo International by 10.7% during the third quarter. Alliancebernstein L.P. now owns 793,927 shares of the medical instruments supplier’s stock valued at $974,633,000 after purchasing an additional 76,478 shares during the period. T. Rowe Price Investment Management Inc. raised its stake in shares of Mettler-Toledo International by 0.5% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 691,565 shares of the medical instruments supplier’s stock valued at $964,174,000 after purchasing an additional 3,157 shares during the period. Finally, Geode Capital Management LLC raised its stake in shares of Mettler-Toledo International by 2.4% during the fourth quarter. Geode Capital Management LLC now owns 597,448 shares of the medical instruments supplier’s stock valued at $830,879,000 after purchasing an additional 14,106 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

(Get Free Report)

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.